中文名 | Imexon |
英文名 | Imexon |
别名 | 伊美克 亚美克松 亚胺氮环己酮 化合物 T15566 4-亚氨基-1,3-二氮杂双环[3.1.0]己-2-酮 |
英文别名 | Imexon imexon bm06002 AMpliMexon Imexon(Amplimexon 4-IMINO-1,3-DIAZABICYCLO-[3.1.0]HEXAN-2-ONE 4-Amino-1,3-diazabicyclo[3.1.0]hex-3-en-2-one 1,3-Diazabicyclo[3.1.0]hex-3-en-2-one, 4-amino- |
CAS | 59643-91-3 |
EINECS | 261-838-2 |
化学式 | C4H5N3O |
分子量 | 111.1 |
密度 | 2.26±0.1 g/cm3(Predicted) |
沸点 | 231.6±23.0 °C(Predicted) |
酸度系数 | 4.79±0.20(Predicted) |
存储条件 | 2-8°C |
体外研究 | Imexon (BM 06002) induces oxidative stress in the ER, activates an ER stress response. Imexon (BM 06002) does not significantly alter the levels of eIF2B5, however there is a dose-dependent increase in the phosphorylation of eIF2alpha, as well as an increase in the levels of GTP exchange protein eIF2B2 in MiaPaCa-2, Panc-1, and BxPC3 cells. Imexon (BM 06002) induces single-stranded breaks in the human A375 melanoma cells but only significantly at the highest concentrations for each agent compared to controls. Imexon plus DTIC cytotoxicity is additive. Imexon (BM 06002) show inhibitory activities against MiaPaCa-2, Panc-1 and BxPC3, with IC 50 s of 275.5 ± 54.2, 147.4 ± 4.7 and 355.7 ± 114.7 μM. |
体内研究 | Imexon (BM 06002) in combination with DTIC results in an increase in the peak plasma imexon level in non-tumor-bearing mice. The combination of both drugs increases plasma imexon AUC by 22% (p=0.026). Imexon (BM 06002) (100 mg/kg/day, i.v.) treatment decreases the body weight of SCID mice bearing human A375 melanoma tumors, but there is no significant difference in tumor growth. Imexon (BM 06002) (100 mg/kg) in combination with GEM shows synergistic inhibition of Panc-1 tumor growth in SCID mice. |
WGK Germany | 3 |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 9.001 ml | 45.005 ml | 90.009 ml |
5 mM | 1.8 ml | 9.001 ml | 18.002 ml |
10 mM | 0.9 ml | 4.5 ml | 9.001 ml |
5 mM | 0.18 ml | 0.9 ml | 1.8 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!